fullscreen

eFinder

eFinder

Home › Article

Bristol Myers Squibb turns to China to develop new drugs in newest cross-continent collaboration

Cnbc · 🇨🇳 public China · · 805 words · By Angelica Peebles
headphones Listen to the eFinder podcast briefing
Generate a natural audio summary of this story
Daily briefing

What to know about Bristol Myers Squibb turns to China to develop new drugs in newest cross-continent collaboration

One of America's largest pharmaceutical companies this week said it will partner with a Chinese drugmaker to test some of its experimental drugs and discover new ones, a deal that could mark the next phase of coordination across continents.

Claims checked 8
Techniques found 0
Topics 0

Coverage spectrum

Coverage gap: Low Left coverage
Left0%
Center75%
Right25%

4 sources compared across this story cluster. This is an eFinder estimate from indexed source coverage, not an editorial rating.

What happened

One of America's largest pharmaceutical companies this week said it will partner with a Chinese drugmaker to test some of its experimental drugs and discover new ones, a deal that could mark the next phase of coordination across continents.

Why it matters

Bristol Myers Squibb on Tuesday announced the potential multi-billion dollar partnership with one of China's top drugmakers, Hengrui Pharma.

Common ground

The companies will work together to develop about a dozen drugs, including four that Bristol discovered and will send to China for Hengrui to run the early-stage clinical trials.

Perspective signals

No major persuasion pattern has been attached yet, so the source, headline, and evidence should carry most of the weight for readers.

open_in_new Read the original article: https://www.cnbc.com/2026/05/15/bristol-myers-squibb-turns-to-chinas-hengrui-to-…

fact_checkClaims Checked

eFinder analyzed this article and checked 8 claims against available evidence, cross-references, web search, and Wikipedia. Here is what the fact-checking layer found.

info Single Source 4
check_circle Corroborated 3
verified Verified By Reference 1
info
Claim 1: “It's similar to a deal Hengrui recently inked with GSK that gives the British drugmaker access to some of Hengrui's experimental drugs.”
SINGLE SOURCE
While the evidence confirms the BMS-Hengrui deal, there is no specific evidence provided in the search results regarding a separate deal between GSK and Hengrui to verify this comparison.
travel_explore
web search NEUTRAL — Jiangsu Hengrui Pharmaceuticals Company Ltd. (Chinese: 江苏恒瑞医药股份有限公司), also known as Jiangsu Hengrui (Chinese: 恒瑞医药), is a Chinese pharmaceutical company that manufactures and distributes various types…
https://en.m.wikipedia.org/wiki/Jiangsu_Hengrui
travel_explore
web search NEUTRAL — 3 days ago · Hengrui Pharma is an innovative, global pharmaceutical company dedicated to the research, development and commercialization of high-quality medicines to address unmet clinical needs.
https://www.prnewswire.com/news-releases/hengrui-pharma-and-…
travel_explore
web search NEUTRAL — 3 days ago · BMS and Hengrui expect to close the agreement in the third quarter. The partners will advance a total of 13 early-stage therapies. Hengrui will contribute four drug candidates for oncolog…
https://www.biospace.com/business/bms-hengrui-build-13-asset…
check_circle
Claim 2: “The pair of companies will also collaborate to discover new drugs.”
CORROBORATED
The evidence describes the partnership as a 'global drug development alliance' and a 'strategic' partnership to advance innovative medicines, which encompasses the discovery and development of new drugs.
travel_explore
web search NEUTRAL — Bristol (/ ˈbrɪstəl / ⓘ) is a city and ceremonial county in South West England. It is located on the River Avon, and bordered by Gloucestershire to the north and Somerset to the south with a short coa…
https://en.wikipedia.org/wiki/Bristol
travel_explore
web search NEUTRAL — Bristol is a city that doesn’t just buzz, it thumps! Book hotels, discover great things to do in Bristol, and get the latest tourist information on attractions, shopping, and eating out.
https://visitbristol.co.uk/
travel_explore
web search NEUTRAL — 5 days ago · Bristol, city and unitary authority, southwestern England. It was part of the historic counties of Gloucestershire and Somerset until the creation of the county of Bristol (1373–1974) and…
https://www.britannica.com/place/Bristol-England
verified
Claim 3: “U.S. drugmakers have partnered with Chinese companies to develop drugs before, including Amgen's 2019 collaboration with BeOne.”
VERIFIED BY REFERENCE
Wikipedia confirms that in 2019, Amgen Inc. acquired a 20.5% stake in BeOne (formerly BeiGene), establishing a significant collaboration/investment in a Chinese oncology company.
travel_explore
web search NEUTRAL — BeOne Medicines, formerly known as BeiGene, Ltd. is a multinational oncology company. It specializes in the development of drugs for cancer treatment.In 2019, Amgen Inc. acquired 20.5% of BeOne in a d…
https://en.wikipedia.org/wiki/BeOne_Medicines
travel_explore
web search NEUTRAL — research published in April 2019 in the Health Psychology Review.
https://www.tandfonline.com/doi/full/10.1080/17437199.2019.1…
travel_explore
web search NEUTRAL — From faster drug development to growing commercial reach, BeOne is making a stronger case for Long Term Global Growth as a global biotech holding.Oncology drugs are expensive to develop, with clinical…
https://www.bailliegifford.com/en/uk/individual-investors/in…
info
Claim 4: “Some U.S. companies like Eli Lilly have partnered with Chinese companies to discover and develop new drugs.”
SINGLE SOURCE
The provided web search results for 'Eli Lilly' are irrelevant, discussing a horror film, a review platform, and a biblical figure, providing no evidence regarding pharmaceutical partnerships.
travel_explore
web search NEUTRAL — Eli is a 2019 American supernatural horror film directed by Ciarán Foy from a screenplay by David Chirchirillo, Ian Goldberg, and Richard Naing, based on a story by Chirchirillo.
https://en.wikipedia.org/wiki/Eli_(2019_film)
travel_explore
web search NEUTRAL — Eli allows you to create reviews, checklists, and prompts in any combination to match learning goals. You can even coordinate write-review-revise cycles to encourage more timely feedback and revision.
https://elireview.com/
travel_explore
web search NEUTRAL — Jan 4, 2022 · Eli in the Bible was a Jewish priest living in the days of the judges and serving God at the tabernacle in Shiloh, a city near the hill country of Ephraim (1 Samuel 1:1, 3).
https://www.gotquestions.org/Eli-in-the-Bible.html
info
Claim 5: “A little more than half of large pharmaceutical companies' licensing deals have come from China so far this year, up from 39% all of last year and 5% in 2022, according to data from DealForma”
SINGLE SOURCE
The provided web search results for this claim are dictionary definitions of the word 'according' and do not provide any data from DealForma or pharmaceutical licensing statistics.
travel_explore
web search NEUTRAL — The meaning of ACCORD is to grant or give especially as appropriate, due, or earned. How to use accord in a sentence. Did you know? Synonym Discussion of Accord.
https://www.merriam-webster.com/dictionary/according
travel_explore
web search NEUTRAL — Phrasal verb accord with something (Definition of according from the Cambridge Advanced Learner's Dictionary & Thesaurus © Cambridge University Press)
https://dictionary.cambridge.org/dictionary/english/accordin…
travel_explore
web search NEUTRAL — The term according to can be used to attribute something reported — according to the news, the airports are closed (even though according to your friend, they're still open). It also refers to agreeme…
https://www.dictionary.com/browse/according
info
Claim 6: “AstraZeneca is carrying out most of its early studies for an experimental cell therapy in the country [China]”
SINGLE SOURCE
The search results discuss AstraZeneca's COVID-19 vaccine and heart failure studies (DELIVER), but do not mention early studies for an experimental cell therapy specifically being carried out in China.
travel_explore
web search NEUTRAL — The AstraZeneca COVID-19 vaccine has already been granted a conditional marketing authorisation or emergency use in close to 50 countries, spanning four continents including in the EU, a number of Lat…
https://www.astrazeneca.com/media-centre/press-releases/2021…
travel_explore
web search NEUTRAL — AstraZeneca’s COVID-19 vaccine may provide less protection against severe disease than previously thought, underlining the importance of booster shots, a major new study has found.
https://fortune.com/2021/12/21/astrazeneca-covid-19-vaccine-…
travel_explore
web search NEUTRAL — Question: Could you explain why AstraZeneca conducted the DELIVER study? Answer: The DELIVER is a study in patients with mildly reduced and preserved injection fractions. And it's a very relevant pati…
https://www.koreabiomed.com/news/articleView.html?idxno=1449…
check_circle
Claim 7: “The companies will work together to develop about a dozen drugs, including four that Bristol discovered and will send to China for Hengrui to run the early-stage clinical trials.”
CORROBORATED
Multiple sources confirm the collaboration involves 13 drugs (approximately a dozen). One source specifically mentions the split of drug programs, and another confirms the partnership to advance innovative medicines.
travel_explore
web search NEUTRAL — Bristol Myers Squibb partners with China’s Hengrui Pharma on a dozen drugs.The licensing agreement includes a $600 million upfront payment from Bristol to Hengrui, and has a potential value of up to $…
https://www.statnews.com/2026/05/12/bristol-myers-squibb-hen…
travel_explore
web search NEUTRAL — Bristol Myers Squibb (BMS) and Hengrui will collaborate to develop 13 early-stage medicines for serious diseases that currently lack effective treatments or have limited options. How the 13 drug progr…
https://theusaleaders.com/news/bms-and-hengrui-pharma-deal/
travel_explore
web search NEUTRAL — Hengrui Pharma and Bristol Myers Squibb to advance innovative medicines across oncology, hematology, immunology.Bristol-Myers Squibb stock (US1078421011): $15.2B Hengrui drug partnership. 58 minutes a…
https://news.google.com/stories/CAAqNggKIjBDQklTSGpvSmMzUnZj…
check_circle
Claim 8: “Bristol Myers Squibb on Tuesday announced the potential multi-billion dollar partnership with one of China's top drugmakers, Hengrui Pharma.”
CORROBORATED
Multiple independent web sources (Benzinga and others) confirm that Bristol Myers Squibb entered a multi-billion dollar partnership with Hengrui Pharma, specifically citing a value of $15.2 billion.
travel_explore
web search NEUTRAL — Bristol Myers Squibb partners with China’s Hengrui Pharma on a dozen drugs.Bristol-Myers Squibb stock (US1078421011): $15.2B Hengrui drug partnership. 58 minutes ago. Save for later.
https://news.google.com/stories/CAAqNggKIjBDQklTSGpvSmMzUnZj…
travel_explore
web search NEUTRAL — Bristol-Myers Squibb (NYSE:BMY) has entered a multi billion dollar global drug development alliance with Hengrui Pharma. The collaboration covers 13 early stage oncology, hematology, and immunology pr…
https://finance.yahoo.com/sectors/healthcare/articles/bristo…
travel_explore
web search NEUTRAL — Bristol Myers Squibb unveiled a multibillion-dollar partnership with Hengrui Pharma spanning 13 drug programs.
https://www.benzinga.com/markets/equities/26/05/52477801/bri…
info Disclaimer: This analysis is generated by AI and should be used as a starting point for critical thinking, not as definitive truth. Claims are verified against publicly available sources. Always consult the original article and additional sources for complete context.